Semaglutides sales reached $21.2 billion in 2023 with an 88% increase, becoming top 3 best-selling drugs worldwide
Retatrutide represents one of the most promising advances in metabolic medicine in recent decades
Some studies indicate GLP-1RAs may help in reducing opioid self-administration and withdrawal symptoms
A record 7.8% in spending growth in 2023 across Rhode Islands health system was partially driven by a surging amount of GLP-1 prescriptions, which doubled from 2022 to 2023
Takeaway : Review your medications prescribing information before travel
Produced by osteoblasts and released into circulationparticularly in its undercarboxylated formosteocalcin has been shown in animal models to enhance insulin secretion, improve insulin sensitivity, increase energy expenditure, and stimulate testosterone production (Lee et al., 2007